Who is sponsoring NCT05278897?

NCT05278897 is sponsored by Global Research Solutions.

What drugs are being tested in NCT05278897?

Interventions in NCT05278897: Soft Tissue Adapted Biocompatible Hyaluronic Acid.

What condition does NCT05278897 study?

NCT05278897 studies Elbow Tendinopathy, Ankle Sprains.

Is NCT05278897 still recruiting?

NCT05278897 is currently status unknown. Last updated 14 March 2022.

Last reviewed 2022-03-14 · How we verify

NCT05278897: SAFE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyaluronic Acid for Soft Tissue Injuries

Status unknown NA Last updated 14 March 2022

What this trial tests

NA trial testing Soft Tissue Adapted Biocompatible Hyaluronic Acid in Elbow Tendinopathy in 200 participants. Status unknown.

Timeline

14 March 2022

Primary endpoint
13 May 2024

13 May 2024

Quick facts

Lead sponsor	Global Research Solutions
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	200
Start date	14 March 2022
Primary completion	13 May 2024
Estimated completion	13 May 2024

Drugs / interventions tested

Soft Tissue Adapted Biocompatible Hyaluronic Acid

Conditions studied

Elbow Tendinopathy — all drugs for Elbow Tendinopathy →
Ankle Sprains — all drugs for Ankle Sprains →

Sponsor

Global Research Solutions

Who can join

18 and older, any sex, with Elbow Tendinopathy or Ankle Sprains. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Soft Tissue Adapted Biocompatible Hyaluronic Acid, or STABHA™, has demonstrated varying degrees efficacy in patients treated for common musculoskeletal tendinopathies and ligament injuries, such as ankle sprains, lateral elbow tendinopathy, and rotator cuff tendinopathies. Factors associated with prognosis following treatment remain largely unknown. Identifying appropriate patient populations for use of STABHA™ is a necessary first step to facilitate the design of future clinical trials in the management of acute and chronic musculoskeletal soft-tissue injuries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Elbow Tendinopathy

Currently open trials in the same condition.

NCT05809622 — Upper Extremity-based Exercises and Elbow-focused Exercises in LET · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05278897 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Global Research Solutions
Last refreshed: 14 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05278897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing